Table 2 Correlation between trephine biopsy indication-based and bone marrow length
Trephine biopsy indications | No. of cases | Percentage (%) | Minimum bone marrow length (cm) | Maximum bone marrow length (cm) | Mean length (cm) | Standard deviation |
|---|---|---|---|---|---|---|
Myeloproliferative neoplasm | 48 | 17.52 | 0.5 | 4 | 2.12 | 0.76 |
Lymphoma | 24 | 8.75 | 0.6 | 3.5 | 2.1 | 0.77 |
Multiple myeloma | 39 | 14.23 | 0.3 | 3.8 | 1.59 | 0.82 |
Acute leukemia | 63 | 22.99 | 0.5 | 3.5 | 1.72 | 0.77 |
Pyrexia of the unknown region | 10 | 3.64 | 0.5 | 2.3 | 1.47 | 0.67 |
Cytopenias user evaluation | 31 | 11.31 | 0.3 | 4 | 1.88 | 0.79 |
Myelodysplastic syndrome | 17 | 6.20 | 0.8 | 4 | 2.28 | 0.76 |
Aplastic anemia | 14 | 5.10 | 0.2 | 3.2 | 1.74 | 0.89 |
Other indications | 28 | 10.21 | 0.2 | 2.9 | 1.77 | 0.69 |